NCT01204320终止4 期
A COMparison Between PAClitaxel-coated Balloon and pacliTaxel-eluting Stent in the Treatment of In-Stent Restenosis (COMPACT-ISR)
适应症
试验速览
- 阶段
- 4 期
- 状态
- 终止
- 入组人数
- 154
- 试验地点
- 2
- 主要终点
- Late Luminal Loss defined as the difference between the minimal luminal diameter after stenting and at follow-up by Quantitative Coronary Analysis
研究概览
简要总结
This is a multicentric randomized comparison between paclitaxel-coated balloon angioplasty or paclitaxel-eluting stent implantation in patients with stable or unstable angina with the evaluation of restenosis by Quantitative Coronary Analysis.
详细描述
The purpose of this study is to determine the late luminal loss by Quantitative Coronary Analysis at 6 month-follow up after paclitaxel-coated balloon angioplasty or paclitaxel-eluting stent implantation in the treatment of in-stent restenosis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •informed consent
- •Stable Angina or Unstable Angina
- •Single restenotic lesion in a previously stented coronary artery
排除标准
- •Acute Myocardial Infarction within 72h
- •Serum Creatinine>2.0 mg/dL
- •Contraindications to ASA, Heparin, Clopidogrel, Ticlopidine, Abciximab, Tirofiban, Paclitaxel
- •Contraindications to contrast media
- •Life expectancy < 2y
- •Target Lesion length > 30mm
- •Target Lesion diameter <= 2.5 mm
- •Target stenosis < 70%
- •Massive Calcifications in the target segment
- •Evidence of intra-coronary thrombus
结局指标
主要结局
Late Luminal Loss defined as the difference between the minimal luminal diameter after stenting and at follow-up by Quantitative Coronary Analysis
时间窗: 6 months
次要结局
- Major Adverse Cardiac Events(6, 12 months)
- Target Lesion Revascularization(6, 12 months)
- Binary restenosis defined as >50% diameter stenosis by QCA(6 months)
研究者
研究点 (2)
Loading locations...
相似试验
招募中
不适用
DCB Versus Primary Selective Stenting in TASC C/D Femoropopliteal Artery DiseaseSafety IssuesEfficacy, SelfNCT05517291Peking Union Medical College Hospital200
已完成
不适用
Paclitaxel-Coated versus Plain Balloon Angioplasty for Dysfunctional Autogenous Radiocephalic Arteriovenous FistulasDiseases of the circulatory systemKCT0004870Gachon University Gil Medical Center40
已完成
2 期
Paclitaxel Eluting Balloon Versus Drug Eluting Stent in Native Coronary Artery Stenoses of Diabetic PatientsCoronary StenosisDiabetes MellitusNCT00462631Heart Centre Rotenburg84
已完成
4 期
Randomized controlled trial for endovascular intervention for dysfunctional dialysis access with drug-coated balloon versus plain balloon angioplastyDysfunctional haemodialysis accessRenal failure on haemodialysisSurgery - Surgical techniquesRenal and Urogenital - Kidney diseaseACTRN12616000789460Department of Surgery, Pamela Youde Nethersole Eastern Hospital, Hong Kong40
已完成
不适用
Compare I Pilot Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery DiseasePeripheral Artery DiseaseNCT02701543University of Leipzig414